|
Rosenblum Mark J
|
Exec VP Finance, CFO |
Salarius Pharmaceuticals, Inc. (SLRX)
|
2025-11-20 |
$0.80 |
0.0% |
20,000
|
$16,000 |
|
Burleson Tess
|
Non-Executive Director |
Salarius Pharmaceuticals, Inc. (SLRX)
|
2022-06-07 |
$540.00 |
-99.7% |
9
|
$4,986 |
|
Lieber Jonathan I
|
Non-Executive Director |
Salarius Pharmaceuticals, Inc. (SLRX)
|
2022-06-07 |
$561.30 |
-99.7% |
12
|
$7,016 |
|
Mcvicar William K.
|
Non-Executive Director |
Salarius Pharmaceuticals, Inc. (SLRX)
|
2022-06-06 |
$564.90 |
-99.7% |
9
|
$5,000 |
|
Hanish Arnold C
|
Non-Executive Director |
Salarius Pharmaceuticals, Inc. (SLRX)
|
2022-06-03 |
$552.00 |
-99.7% |
9
|
$5,152 |
|
Rosenblum Mark J
|
Exec VP Finance |
Salarius Pharmaceuticals, Inc. (SLRX)
|
2022-05-31 |
$540.00 |
-99.7% |
9
|
$5,040 |
|
Arthur David J.
|
Chief Executive Officer |
Salarius Pharmaceuticals, Inc. (SLRX)
|
2022-05-26 |
$545.64 |
-99.7% |
15
|
$7,985 |
|
Rosenblum Mark J
|
Exec VP Finance |
Salarius Pharmaceuticals, Inc. (SLRX)
|
2022-03-03 |
$1173.00 |
-99.9% |
25
|
$29,812 |
|
Arthur David J.
|
Chief Executive Officer |
Salarius Pharmaceuticals, Inc. (SLRX)
|
2022-03-03 |
$1173.00 |
-99.9% |
46
|
$54,540 |
|
Arthur David J.
|
Chief Executive Officer |
Salarius Pharmaceuticals, Inc. (SLRX)
|
2021-08-17 |
$2686.50 |
-99.9% |
1
|
$3,582 |
|
Hanish Arnold C
|
Non-Executive Director |
Salarius Pharmaceuticals, Inc. (SLRX)
|
2021-08-10 |
$2643.00 |
-99.9% |
2
|
$6,167 |
|
Hanish Arnold C
|
Non-Executive Director |
Salarius Pharmaceuticals, Inc. (SLRX)
|
2020-08-21 |
$2940.00 |
-99.9% |
1
|
$3,920 |
|
Arthur David J.
|
Chief Executive Officer |
Salarius Pharmaceuticals, Inc. (SLRX)
|
2020-08-19 |
$3030.00 |
-99.9% |
1
|
$2,020 |
|
Rosenblum Mark J
|
Exec VP Finance |
Salarius Pharmaceuticals, Inc. (SLRX)
|
2020-08-17 |
$3000.00 |
-99.9% |
2
|
$5,000 |
|
Rosenblum Mark J
|
Exec VP Finance |
Salarius Pharmaceuticals, Inc. (SLRX)
|
2020-02-19 |
$2850.00 |
-99.9% |
1
|
$1,900 |
|
Jordan Scott
|
Chief Business Officer |
Salarius Pharmaceuticals, Inc. (SLRX)
|
2020-02-18 |
$2700.00 |
-99.9% |
4
|
$10,170 |
|
Rosenblum Mark J
|
Exec VP Finance |
Salarius Pharmaceuticals, Inc. (SLRX)
|
2020-02-13 |
$2577.00 |
-99.9% |
2
|
$4,295 |
|
Burleson Tess
|
Non-Executive Director |
Salarius Pharmaceuticals, Inc. (SLRX)
|
2020-02-11 |
$3450.00 |
-100.0% |
1
|
$5,002 |
|
Hanish Arnold C
|
Non-Executive Director |
Salarius Pharmaceuticals, Inc. (SLRX)
|
2020-02-11 |
$3450.00 |
-100.0% |
1
|
$5,002 |
|
Arthur David J.
|
Chief Executive Officer |
Salarius Pharmaceuticals, Inc. (SLRX)
|
2020-02-11 |
$3450.00 |
-100.0% |
1
|
$2,501 |
|
Mcvicar William K.
|
Non-Executive Director |
Salarius Pharmaceuticals, Inc. (SLRX)
|
2020-02-11 |
$3450.00 |
-100.0% |
3
|
$10,005 |
|
Northrup Jonathan P
|
Non-Executive Director |
Salarius Pharmaceuticals, Inc. (SLRX)
|
2020-02-11 |
$3450.00 |
-100.0% |
3
|
$10,005 |
|
Mccreedy Bruce J Jr.
|
Non-Executive Director |
Salarius Pharmaceuticals, Inc. (SLRX)
|
2020-02-11 |
$3450.00 |
-100.0% |
3
|
$10,005 |